Synthetic Biology
Histone Demethylase (HDM) Inhibitors

Histone Demethylase (HDM) Inhibitors

Home / Products / Biosynthesis Chemicals / Enzyme Inhibitors / Histone Demethylase (HDM) Inhibitors /

Histone Demethylase (HDM) Inhibitors

Histone demethylase (HDM) inhibitors are a class of compounds that have shown great potential in the field of epigenetics research These inhibitors target enzymes known as histone demethylases which play a crucial role in the removal of methyl groups from histone proteins By inhibiting these enzymes HDM inhibitors can alter the modification status of histones leading to changes in gene expression patterns This ability to modulate gene expression through epigenetic mechanisms has opened up new avenues for therapeutic interventions in various diseases including cancer Our company offers a range of high-quality HDM inhibitors that researchers can utilize to explore the complex intricacies of epigenetic regulation

Catalog Number Chemical Name CAS # Price
BC-0607 Lysine-specific Demethylase Inhibitor (1C) (Hydrochloride) 1234494-75-7 Online Inquiry
BC-0662 Tranylcypromine Hemisulfate 13492-01-8 Online Inquiry
BC-0703 Ebselen 60940-34-3 Online Inquiry
EI-0234 AS8351 796-42-9 Online Inquiry
EI-0492 Caffeic acid 331-39-5 Online Inquiry
EI-0626 Clorgyline hydrochloride 17780-75-5 Online Inquiry
EI-0655 CPI-455 1628208-23-0 Online Inquiry
EI-0656 CPI-455 hydrochloride 2095432-28-1 Online Inquiry
EI-0706 Daminozide 1596-84-5 Online Inquiry
EI-0718 DDP-38003 dihydrochloride 1831167-98-6 Online Inquiry
EI-0743 Disulfiram 97-77-8 Online Inquiry
EI-1105 GSK-2879552 1401966-69-5 Online Inquiry
EI-1125 GSK-J1 (Free acid) 1373422-53-7 Online Inquiry
EI-1126 GSK-J4 (Free base) 1373423-53-0 Online Inquiry
EI-1127 GSK-LSD1 dihydrochloride 1431368-48-7 Online Inquiry

Application

Histone Demethylase (HDM) inhibitors play a crucial role in epigenetic research allowing scientists to study and understand the modifications that occur on histone proteins These inhibitors are used to block the activity of histone demethylases enzymes responsible for removing methyl groups from histones thereby influencing gene expression patterns By inhibiting these enzymes researchers can gain valuable insights into the role of histone modifications in various biological processes including development disease progression and potential therapeutic interventions Additionally HDM inhibitors have the potential to be developed into targeted therapies offering promising options for the treatment of diseases such as cancer where aberrant histone modifications often play a role

Please note that all services are for research use only. Not intended for any clinical use.

Synthetic Biology Products

Online Inquiry